Literature DB >> 27233663

Coronary Artery Dilatation in Viral Myocarditis Mimics Coronary Artery Findings in Kawasaki Disease.

Soha Rached-D'Astous1,2, Ibtissama Boukas3, Anne Fournier1, Marie-Josée Raboisson1, Nagib Dahdah4.   

Abstract

Coronary artery (CA) dilatations are typical to Kawasaki disease (KD) in the pediatric population. CA involvement is a useful feature to help establish the diagnosis of KD. Since myocarditis is omnipresent in the acute phase of KD, we sought to investigate whether viral myocarditis may cause CA dilatation. This retrospective study reviewed 14 consecutive patients diagnosed with acute myocarditis at CHU Sainte-Justine, Montreal. KD diagnosis was excluded for all patients. All echocardiography studies were reviewed by an independent experienced echocardiographer for CA size and myocardial function parameters. CA involvement was classified under three categories: definite dilatation (Z-score ≥2.5 in one or more CA), occult dilatation (Z-score variation ≥2 points for the same CA on two different echocardiograms, but maximum Z-score always <2.5), and no dilatation otherwise. Demographics, laboratory values, microbial etiology testing, and diagnostic studies were collected from medical records. Mean age at presentation was 1.67 ± 3.22 years, where 11/14 (78 %) presented with acute and three with subacute myocarditis. Five (36 %) patients had normal CA measurements, six (43 %) had occult dilatation, and three (21 %) had definite dilatation. Maximal CA Z-score was within the first 8 days of presentation. Patients with viral myocarditis can present CA dilatation during the acute phase of the illness. This finding should be taken into account when KD diagnosis is being based on the CA involvement as the two illnesses may present with similar features.

Entities:  

Keywords:  Coronary dilatation; Inflammation; Kawasaki disease; Myocarditis

Mesh:

Year:  2016        PMID: 27233663     DOI: 10.1007/s00246-016-1411-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  21 in total

Review 1.  Myocarditis.

Authors:  A M Feldman; D McNamara
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

2.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

Review 3.  The management of myocarditis.

Authors:  Heinz-Peter Schultheiss; Uwe Kühl; Leslie T Cooper
Journal:  Eur Heart J       Date:  2011-06-23       Impact factor: 29.983

4.  Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms.

Authors:  H Kikuta; Y Sakiyama; S Matsumoto; I Hamada; M Yazaki; T Iwaki; M Nakano
Journal:  J Pediatr       Date:  1993-07       Impact factor: 4.406

5.  Echocardiographic findings in fulminant and acute myocarditis.

Authors:  G M Felker; J P Boehmer; R H Hruban; G M Hutchins; E K Kasper; K L Baughman; J M Hare
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

7.  Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe.

Authors:  C Kampmann; C M Wiethoff; A Wenzel; G Stolz; M Betancor; C F Wippermann; R G Huth; P Habermehl; M Knuf; T Emschermann; H Stopfkuchen
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

8.  Coronary artery dimensions in febrile children without Kawasaki disease.

Authors:  Juan-Carlos G Muniz; Kirsten Dummer; Kimberlee Gauvreau; Steven D Colan; David R Fulton; Jane W Newburger
Journal:  Circ Cardiovasc Imaging       Date:  2013-01-28       Impact factor: 7.792

9.  Pediatric myocarditis: presenting clinical characteristics.

Authors:  Yamini Durani; Matthew Egan; Jeanne Baffa; Steven M Selbst; Alan L Nager
Journal:  Am J Emerg Med       Date:  2009-10       Impact factor: 2.469

10.  Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines.

Authors:  Paul F Kantor; Jane Lougheed; Adrian Dancea; Michael McGillion; Nicole Barbosa; Carol Chan; Rejane Dillenburg; Joseph Atallah; Holger Buchholz; Catherine Chant-Gambacort; Jennifer Conway; Letizia Gardin; Kristen George; Steven Greenway; Derek G Human; Aamir Jeewa; Jack F Price; Robert D Ross; S Lucy Roche; Lindsay Ryerson; Reeni Soni; Judith Wilson; Kenny Wong
Journal:  Can J Cardiol       Date:  2013-12       Impact factor: 5.223

View more
  1 in total

1.  Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States.

Authors:  Daisuke Matsubara; Hunter L Kauffman; Yan Wang; Renzo Calderon-Anyosa; Sumekala Nadaraj; Matthew D Elias; Travus J White; Deborah L Torowicz; Putri Yubbu; Therese M Giglia; Alexa N Hogarty; Joseph W Rossano; Michael D Quartermain; Anirban Banerjee
Journal:  J Am Coll Cardiol       Date:  2020-09-02       Impact factor: 24.094

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.